common variable
immunodeficiency (CVID) 2:255
community sanitation 2:360, 363;
4: 2 , 17–18,19–21, 41
co-morbidities 4:292, 302
compact bone 1:308, 309
complement 2:239, 255
complementary therapies 4:78, 91
complement cascade 2:255–256
antibody-mediated immunity
2: 246
corticosteroid medications 2: 256
hypersensitivity reaction 2: 268
immune response 2:272–273
immune system 2: 236
immunoglobulin 2: 275
immunosuppressive medications
2: 276
mononuclear phagocyte system
2:283–284
complement factors 2:236, 255,
277
complex regional pain syndrome
1:371–372
computed tomography (CT) scan
1:311; 3: 27
conception 1:217; 3:236, 242, 264,
267, 272, 282, 287, 293
concussion 1:244–245, 245 t;4: 378
conditioning 4: 217 , 217–218
conduct disorder 3:369; 4: 335
cones 1:91, 113, 114
confidentiality 4: 272 , 358
congenital anomaly 4:120
albinism 1:135–136
amniocentesis 3: 244
anal atresia 3: 10
arthrogryposis 1:303–304
bladder exstrophy 3: 182
bowel atresia 3: 20
chordee 3: 262
cleft palate/cleft palate and lip
1:16
congenital hip dysplasia
1:318–319
CVS 3: 262
Down syndrome 4: 122
enuresis 3:187, 188
epispadias 3: 188
esophageal atresia 3: 40
fecal incontinence 3: 44
Hirschsprung’s disease 3: 58
horseshoe kidney 3: 195
hydrocele 3: 290
hydronephrosis 3: 196
hypospadias 3: 197
kyphosis 1: 332
lactose intolerance 4: 185
laryngocele 1: 32
lordosis 1: 334
meconium 3: 77
nephrectomy 3: 206
neural tube defects 4: 39
optic nerve hypoplasia 1:106
ovarian cyst 3: 313
phimosis 3: 319
rectal fistula 3: 86
retinoblastoma 1:114
talipes equinovarus 1:358
temporomandibular disorders
1: 359
torticollis 1: 360
urethral stricture 3: 222
VACTERL 3: 352
vesicoureteral reflux 3: 229
congenital cataracts 1:77; 4: 123
congenital heart disease 1:16;
2:5–6, 34, 37–40, 38 t,61, 102,
183; 3:87, 352
congenital hip dysplasia 1:318–319
congenital vision loss 1:106, 114
congestive heart failure 2:16, 31,
58, 76, 124
conjunctiva 1:80, 108, 110
conjunctivitis 1:80, 87 ,95–97,352;
2:240, 317
connective tissue 2:55, 391; 4: 265
Achilles tendon 1:297
Achilles tendon injury
1:297–298
aging and integumentary
changes 1:134–135
dermatofibroma 1:152
fascia 1: 321
fibromyalgia 1:321–322
integumentary system 1: 128
Kaposi’s sarcoma 1:168–169
Marfan syndrome 1:335–336
consciousness 1:245; 4:77, 166,
262, 344, 385. See also
unconsciousness
constipation 3:32–33
antidepressant medications
3: 361
enema 3: 40
exercise and health 4: 221
Fanconi’s syndrome 3: 190
fecal impaction 3: 43
fiber and gastrointestinal health
3: 45
Hirschsprung’s disease 3: 58
narcotics 4: 344rectal prolapse 3: 87
steatorrhea 3: 90
consumption (tuberculosis) 2:304,
359
contact dermatitis 1:150, 185;
4: 382
contact lens 1:67, 83–84, 90, 109
contact lens, implantable 1:101,
112
contact toxins 4:42, 381, 382–383,
383 t, 386
continuous positive airway pressure
(CPAP) 1:39; 2:214, 223
contraception 3:264–267,
265 t–266t;4: 46
breastfeeding 3: 253
conception 3: 264
dysmenorrhea 3: 270
fallopian tubes 3: 281
family planning 3: 281
sexual health 3: 339
tubal ligation 3: 347
vasectomy 3: 354
contracture 1:319
conversion disorder 3:369
cool laser. Seeexcimer laser
COPD. Seechronic obstructive
pulmonary disease
coping mechanisms 3:369–370,
373 , 377
coping with cancer 2:377
copper 4:31, 177, 187
cornea 1:80–81
astigmatism 1:73
bullous keratopathy 1:76
cicatricial pemphigoid 1: 79
cold sore 1: 17
conjunctivitis 1: 80
corneal injury 1:81
corrective lenses 1: 82
ectropion 1: 87
entropion 1: 87
eye 1: 89
keratitis 1:99
keratoconus 1:99
ocular herpes simplex 1: 103
pterygium 1: 110
PTK 1: 108
corneal injury 1:81, 91 , 103
corneal transplantation 1:81–82
corns 1:145–146
coronary arteries 2:40–41; 4: 320
angina pectoris 2: 11
aorta 2: 16
atherectomy 2: 21
atherosclerosis 2: 21Index 461